Central administration of palmitoylethanolamide lowers hyperalgesia in mice via inhibition of NF‐κB nuclear signalling in dorsal root ganglia. Eur J Pharmacol The anti‐inflammatory outcomes of PEA appear to be primarily connected to its power to modulate mast mobile activation and degranulation, which action is also known as the ALIA https://chronic-pain53074.isblog.net/a-review-of-palmitoylethanolamide-47746812